|
⚲
|
| Linden Advisors LP
✚
|
|
|---|---|
| CRD # | 135431 |
| SEC # | 801-65641 |
| CIK # | 0001279396 |
| AUM | $15.1 BB (2023-03-20) |
| Employees | 43 (51% Investors, 0% Brokers) |
| Phone | 646-840-3500 |
| Address | 590 Madison Avenue New York, NY 10022 |
| Source | [IAPD] [EDGAR] [Website] |
| Total AUM ($BB) |
|---|
| Type | Form D Funds | Date | Sold ($MM) | AUM ($MM) |
|---|---|---|---|---|
| HF | PCH Manager Fund SPC - Segregated Portfolio 214 | [2019-10-28] | 132.5 | 529.1 |
| HF | Linden Focused Metric Fund Ltd | [2016-02-26] | 1.0 | 0.0 |
| HF | Linden Capital LP | [2012-03-29] | 706.4 | 14,209.1 |
| AUM Breakdown | Accounts | AUM ($BB) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 5 | 15.1 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 5 | 15.1 |
| By Discretionary | ||
| Discretionary | 5 | 15.1 |
| Non-Discretionary | 0 | 0.0 |
| Total | 5 | 15.1 |
| By Non-United States Persons | ||
| Non-United States Persons | 15.1 | |
| United States Persons | 0.0 | |
| Total | 5 | 15.1 |
| Form D Directors | # Filings | # Firms | 2011 - 2024 |
|---|---|---|---|
| Michelle WilsonClarke | 272 | ||
| John Ackerley | 160 | ||
| Carlos Ferreira | 88 | ||
| James Keyes | 152 | ||
| Roderick Forrest | 34 | ||
| Vincent Cuticello | 20 | ||
| Nicholas Hoskins | 22 | ||
| Linden Advisors LP | 2 | ||
| Saul Ahn | 2 |
| EDGAR Form | CIK | 2011 - 2024 |
|---|---|---|
| 13F-HR | [0001279396] | |
| 3 | [0001279396] | |
| 4 | [0001279396] | |
| SC 13D | [0001279396] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Linden Advisors LP | Tetralogic Pharmaceuticals Corp | [2016-11-14] |
| Form 3/4/5 Subject | 2011 - 2024 |
|---|---|
| Linden Capital L.P. | |
| TETRALOGIC PHARMACEUTICALS Corp | |
| Linden Advisors LP |
| Comparable Firms | State | AUM ($BB) |
|---|---|---|
|
The Rock Creek Group LP
✚
|
DC | 15.7 |
|
Onex Credit Partners LLC
✚
|
NJ | 15.7 |
|
Graham Capital Management LP
✚
|
CT | 15.5 |
|
Centiva Capital LP
✚
|
NY | 15.3 |
|
Blackstone Credit Systematic Strategies LLC
✚
|
NY | 15.3 |
|
Alyeska Investment Group LP
✚
|
IL | 15.0 |
|
UBS OConnor LLC
✚
|
IL | 14.9 |
|
Lee Overlay Partners Ltd
✚
|
14.9 | |
|
Hildene Capital Management LLC
✚
|
CT | 14.6 |
|
Diameter Capital Partners LP
✚
|
NY | 14.6 |